Company Encyclopedia
View More
name
GOLDEN THROAT
06896.HK
Golden Throat Holdings Group Company Limited, an investment holding company, manufactures and sells pharmaceutical, healthcare food, and other products in the People’s Republic of China and internationally. The company offers Golden Throat Lozenges, an over-the-counter medicine to relieve symptoms of sore and dry throat, and hoarse voice caused by acute pharyngitis. It also provides Golden Throat Lozenge series products, which include Dule Lozenges; sugar-free Dule Lozenges; and other sugar free flavours, such as orange, fructus momordicae, chrysanthemum, American ginseng, and hawthorn. In addition, the company offers Yinxingye tablets to facilitate blood circulation, remove blood stasis, and dredge energy channels; Golden Throat intestinal series for probiotics; and Golden Throat Compound Probiotic Lozenges.
187.24 B
06896.HKMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
C
Personal Care ProductsIndustry
Industry Ranking10/20
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreA
    • ROE21.53%A
    • Profit Margin27.37%A
    • Gross Margin77.16%A
  • Growth ScoreD
    • Revenue YoY-2.49%D
    • Net Profit YoY2.40%C
    • Total Assets YoY4.24%C
    • Net Assets YoY-4.08%D
  • Cash ScoreC
    • Cash Flow Margin365.41%C
    • OCF YoY-2.49%D
  • Operating ScoreC
    • Turnover0.47C
  • Debt ScoreC
    • Gearing Ratio43.08%C

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    GOLDEN THROAT released its interim results, with a net profit attributable to the parent company of 83.674 million yuan, a year-on-year decrease of 37.65%

    GOLDEN THROAT released its interim results for the period ending June 30, 2025, with revenue of 319 million yuan, a year-on-year decrease of 39.14%; net profit attributable to shareholders of 83.674 million yuan, a year-on-year decrease of 37.65%; and basic loss per share of 11.32 cents. The announcement pointed out that the decrease in revenue was mainly due to changes in industry conditions and adjustments in product marketing strategies in the first half of 2025, leading to a reduction in purchases by customer distributors

    Zhitong·
    HK
    06896
    -0.31%
    Zhitong·
    HK
    06896
    -0.31%

    Golden Throat Holdings Reports 39.1% Revenue Drop to RMB319.2 Million and 37.6% Profit Decline in H1 2025

    Golden Throat Holdings Group Co. Ltd. reported a 39.1% revenue drop to RMB319.2 million and a 37.6% decline in profit to RMB83.7 million for H1 2025. Gross profit decreased by 37.1% to RMB246.3 million, and earnings before interest, taxes, depreciation, and amortization fell by 35.6% to RMB125.9 million. The Board of Directors did not recommend any interim dividend, indicating a challenging financial period for the company compared to the previous year.

    Reuters·
    HK
    06896
    -0.31%
    Reuters·
    HK
    06896
    -0.31%

    GOLDEN THROAT issues profit warning, expects a decrease of approximately 37% in profit for the first half of the year

    According to the Zhitong Finance APP, GOLDEN THROAT announced that compared to the same period in 2024, for the six months ending June 30, 2025, the Group expects a decrease in profit of approximately 37%. The decrease in profit is mainly due to changes in the industry situation in the first half of 2025, as the Group adjusted its product marketing strategy, resulting in a reduction in purchases by customer distributors in the first half of 2025, leading to a decline in the Group's sales and profit during that period

    Zhitong·
    HK
    06896
    -0.31%
    Zhitong·
    HK
    06896
    -0.31%

    GOLDEN THROAT throat lozenge products received certification from the Ministry of Health of Uzbekistan

    GOLDEN THROAT announced that its Throat Treasure product has been confirmed by a testing report from an Uzbek laboratory and recognized by the Uzbek Ministry of Health as having metabolic regulation and immune support functions, marking a key step in the company's international layout. GOLDEN THROAT stated that after more than a decade of expanding into overseas markets, its product matrix now covers over 60 countries and regions across five continents, and it believes that with the continuous increase in brand awareness, its competitiveness in the global market will further enhance

    AASTOCKS·
    HK
    06896
    -0.31%
    AASTOCKS·
    HK
    06896
    -0.31%

    Hong Kong Stock Concept Tracking | The Trend of COVID-19 Infections is Rising, Antiviral Drug Companies Attract Attention (Including Concept Stocks)

    Recently, the trend of COVID-19 infections has risen in the Hong Kong and Macau regions. The Hong Kong Special Administrative Region Government's Department of Health reported that the positive rate of COVID-19 tests increased from 1.71% in April to 8.21%. The number of emergency visits in Taiwan Province surged by 66%, with an increase in severe cases and deaths. Experts remind that young people can usually recover on their own after infection, but the elderly still need to be vigilant about the risk of severe illness. Related antiviral drug companies such as SHANDONG XINHUA and GOLDEN THROAT have attracted attention

    Zhitong·
    SZ
    000756
    -1.69%
    HK
    00719
    -0.85%
    HK
    06896
    -0.31%
    Zhitong·
    SZ
    000756
    -1.69%
    HK
    00719
    -0.85%
    HK
    06896
    -0.31%
    © 2025 Longbridge｜Disclaimer